Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 6/20 | 0.58 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30386846 | 0.85 | TYR (0.67) | TYRALOX5MEN1MAPTKMT2A | |
| SCHEMBL3197381 | 0.85 | TYR (0.67) | TYRALOX5MEN1MAPTKMT2A | |
| SCHEMBL9734205 | 0.84 | GABRA1 (0.50) | TYRGABRA1GABRB2 | |
| SCHEMBL14983869 | 0.83 | TYR (0.46) | TYRGABRA1GABRB2ALOX5MEN1 | |
| SCHEMBL14478262 | 0.83 | TYR (0.55) | TYR | |
| SCHEMBL3138811 | 0.83 | TYR (0.55) | TYR | |
| SCHEMBL5877825 | 0.83 | GABRA1 (0.68) | TYRGABRA1GABRB2ALOX5MEN1 | |
| SCHEMBL2292664 | 0.81 | GABRA1 (0.71) | GABRA1GABRB2ALOX5MEN1MAPT | |
| SCHEMBL21503461 | 0.81 | GABRA1 (0.50) | TYRGABRA1GABRB2 | |
| SCHEMBL3953639 | 0.81 | TRPA1 (0.50) | TYRGABRA1GABRB2MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184498-A | Supermolecule resorcinol-licochalcone A-ion salt and preparation method and application thereof | 百特威(上海)化妆品有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-116867474-A | Double-layer cosmetic | 株式会社资生堂 | 2023-10-10 | — | — | CN | claimed |
| CN-115919671-A | Anti-aging freeze-dried mask beneficial to storage | 常州伟博海泰化妆品有限公司 | 2023-04-07 | — | — | CN | claimed |
| WO-2022196480-A1 | DOUBLE-LAYER COSMETIC | 株式会社 資生堂 | 2022-09-22 | — | — | WO | claimed |
| CN-115006279-A | Clathrate compound and preparation method thereof, external preparation and preparation method thereof | 沈阳药科大学 | 2022-09-06 | — | — | CN | claimed |
| EP-2292208-B1 | EXTERNAL PREPARATION FOR SKIN | SHISEIDO CO LTD (JP) | 2017-07-19 | — | — | EP | claimed |
| US-9101564-B2 | Heparanase activity inhibitor, wrinkle improving agent containing same, and pharmaceutical composition | SHISEIDO COMPANY, LTD. (JP) | 2015-08-11 | — | — | US | claimed |
| US-8486997-B2 | External preparation for skin | SHISEIDO COMPANY (JP) | 2013-07-16 | — | — | US | claimed |
| EP-2484349-A1 | HEPARANASE-ACTIVITY INHIBITOR, WRINKLE AMELIORATING AGENT CONTAINING SAME, AND PHARMACEUTICAL COMPOSITION | Shiseido Co., Ltd. (JP) | 2012-08-08 | — | — | EP | claimed |
| US-20120184782-A1 | HEPARANASE ACTIVITY INHIBITOR, WRINKLE IMPROVING AGENT CONTAINING SAME, AND PHARMACEUTICAL COMPOSITION | SHISEIDO COMPANY, LTD. | 2012-07-19 | — | — | US | claimed |
| US-20110213030-A1 | External Preparation For Skin | SHISEIDO COMPANY, LTD. (JP) | 2011-09-01 | — | — | US | claimed |
| EP-2292208-A1 | EXTERNAL PREPARATION FOR SKIN | Shiseido Company, Ltd. (JP) | 2011-03-09 | — | — | EP | claimed |
| US-4487975-A | Etherification of phenols | RHONE-POULENC INDUSTRIES (FR) | 1984-12-11 | — | — | US | claimed |
| CN-118265517-A | Oil-in-water type emulsified cosmetic | 株式会社资生堂 | 2024-06-28 | — | — | CN | disclosed |
| CN-118184498-A | Supermolecule resorcinol-licochalcone A-ion salt and preparation method and application thereof | 百特威(上海)化妆品有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-116867474-A | Double-layer cosmetic | 株式会社资生堂 | 2023-10-10 | — | — | CN | disclosed |
| EP-0277907-A2 | Low temperature synthesis of condensation polymers | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-08-10 | — | — | EP | disclosed |
| US-4668762-A | OXYGEN-SILICON-PHOSPHORUS-CONTAINING COMPOUNDS, ACID ACCEPTORS AND HALO COMPOUND TO MAKE POLYESTERS,-UREAS AND AMIDES AT LOW TEMPERATURE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1987-05-26 | — | — | US | disclosed |
| US-4487975-A | Etherification of phenols | RHONE-POULENC INDUSTRIES (FR) | 1984-12-11 | — | — | US | disclosed |
| US-4225619-A | BACTERICIDES, FUNGICIDES | BOEHRINGER INGELHEIM GMBH (DE) | 1980-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120184782-A1 | HEPARANASE ACTIVITY INHIBITOR, WRINKLE IMPROVING AGENT CONTAINING SAME, AND PHARMACEUTICAL COMPOSITION | HPSE, MMP7, COLGALT1 | TYR 1311/4885GABRA1 4368/4885GABRB2 4369/4885 |
| US-20110213030-A1 | External Preparation For Skin | CYP46A1, PROC, CYP24A1 | TYR 686/4885GABRA1 4544/4885GABRB2 4409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.